ANA (IBEX 35) +103,0000 (0,98 %)

What are you searching?

Analyst opinion

Analyst opinion graphic
Institution Analyst Target
Price
Recommendation Date
Alphavalue Felix Brunotte 128,00 Buy 18-04-19
BBVA Isidoro del Álamo 88,10 Sell 17-04-19
Goldman Sachs Alberto Gandolfi 85,00 Hold 16-04-19
Alantra Fernando Lafuente 93,51 Sell 12-04-19
Exane BNP Manuel Palomo 89,00 Hold 10-04-19
GVC Gaesco Rafael Fernández de Heredia 86,40 Buy 05-04-19
Sabadell Alfredo del Cerro 81,65 Sell 01-04-19
Santander Óscar Nájar  83,00 Sell 01-04-19
Fidentiis Daniel Rodríguez 108,50 Buy 18-03-19
Citi Antonella Bianchessi 92,00 Hold 04-03-19
Macquaire José Javier Ruiz 84,00 Hold 04-03-19
JB Capital Markets Daniel Gandoy 95,50 Buy 01-03-19
Bankinter Pedro Echeguren 93,30 Buy 27-02-19
Kepler Cheuvreux José Porta 92,00 Buy 26-02-19
Renta 4 Ángel Pérez Llamazares 96,05 Buy 04-01-19
HSBC Sean McLoughlin 83,00 Hold 12-12-18
Caixabank BPI Gonzalo Sánchez Bordona 96,50 Hold 27-11-18

Last update: 24-04-19


Research Coverage


Institution Analyst
Alantra Fernando Lafuente
Alpha Value Felix Brunotte
Bankinter Securities Pedro Echeguren
Bankinter Aránzazu Bueno
BBVA Isidoro del Álamo
CaixaBank BPI Gonzalo Sánchez Bordona
Citi Antonella Bianchessi
Exane BNP Paribas Manuel Palomo
Fidentiis Daniel Rodríguez
Goldman Sachs Baptiste Cota
GVC Gaesco Beka Rafael Fernández de Heredia
Haitong Bank Filipe Rosa
HSBC Sean Mcloughlin
Mirabaud Álvaro Navarro
JB Capital Markets

Daniel Gandoy

Miguel González Toquero

Kepler Cheuvreux José Porta
Macquarie José Javier Ruiz
Mirabaud Alvaro Navarro
Norbolsa Ruben Escobedo Olabarria
Renta 4 Ángel Perez Llamazares
Sabadell Alfredo del Cerro
Santander Óscar Nájar


LEGAL NOTE

ACCIONA is monitored by analysts whose reports are published regularly. We would ask you to remember that whatever opinions, estimates or forecasts they make with reference to ACCIONA, these belong to the analysts themselves and do not represent the opinions, estimates or forecasts made by ACCIONA or its management. ACCIONA neither accepts liability for the analysts' information, nor for their conclusions or recommendations.

Move up